Format
Sort by

Send to

Choose Destination

Links from PubChem BioAssay

Items: 1 to 20 of 22

1.

The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.

Bradaia A, Trube G, Stalder H, Norcross RD, Ozmen L, Wettstein JG, Pinard A, Buchy D, Gassmann M, Hoener MC, Bettler B.

Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20081-6. doi: 10.1073/pnas.0906522106. Epub 2009 Nov 5.

2.

Structural diversity of G protein-coupled receptors and significance for drug discovery.

Lagerström MC, Schiöth HB.

Nat Rev Drug Discov. 2008 Apr;7(4):339-57. doi: 10.1038/nrd2518. Review. Erratum in: Nat Rev Drug Discov. 2008 Jun;7(6):542.

PMID:
18382464
3.

Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease.

Thompson MD, Cole DE, Jose PA.

Methods Mol Biol. 2008;448:77-107. doi: 10.1007/978-1-59745-205-2_6. Review.

PMID:
18370232
4.

Modulation of pain transmission by G-protein-coupled receptors.

Pan HL, Wu ZZ, Zhou HY, Chen SR, Zhang HM, Li DP.

Pharmacol Ther. 2008 Jan;117(1):141-61. Epub 2007 Sep 22. Review.

5.

Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance.

Bosier B, Hermans E.

Trends Pharmacol Sci. 2007 Aug;28(8):438-46. Epub 2007 Jul 13. Review.

PMID:
17629964
6.

A rapid functional assay for the human trace amine-associated receptor 1 based on the mobilization of internal calcium.

Navarro HA, Gilmour BP, Lewin AH.

J Biomol Screen. 2006 Sep;11(6):688-93. Epub 2006 Jul 10.

PMID:
16831861
7.

Trace amines reduce GABA(B) receptor-mediated presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta.

Berretta N, Giustizieri M, Bernardi G, Mercuri NB.

Brain Res. 2005 Nov 16;1062(1-2):175-8. Epub 2005 Nov 2.

PMID:
16263097
8.

The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?

Mercuri NB, Bernardi G.

Trends Pharmacol Sci. 2005 Jul;26(7):341-4. Review.

PMID:
15936832
9.

Primate trace amine receptor 1 modulation by the dopamine transporter.

Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, Madras BK.

J Pharmacol Exp Ther. 2005 Jun;313(3):983-94. Epub 2005 Mar 11.

10.

Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors.

Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC.

Genomics. 2005 Mar;85(3):372-85.

PMID:
15718104
11.

Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels.

Federici M, Geracitano R, Tozzi A, Longone P, Di Angelantonio S, Bengtson CP, Bernardi G, Mercuri NB.

Mol Pharmacol. 2005 Apr;67(4):1283-90. Epub 2005 Jan 11.

12.

Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia.

Duan J, Martinez M, Sanders AR, Hou C, Saitou N, Kitano T, Mowry BJ, Crowe RR, Silverman JM, Levinson DF, Gejman PV.

Am J Hum Genet. 2004 Oct;75(4):624-38. Epub 2004 Aug 24.

13.

Trace amine receptors as targets for novel therapeutics: legend, myth and fact.

Branchek TA, Blackburn TP.

Curr Opin Pharmacol. 2003 Feb;3(1):90-7. Review.

PMID:
12550748
14.

Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK.

Mol Pharmacol. 2001 Dec;60(6):1181-8.

15.

Following the trace of elusive amines.

Premont RT, Gainetdinov RR, Caron MG.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9474-5. No abstract available.

16.

Trace amines: identification of a family of mammalian G protein-coupled receptors.

Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald C.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):8966-71. Epub 2001 Jul 17.

17.

Neurochemical and metabolic aspects of antidepressants: an overview.

Baker GB, Coutts RT, Greenshaw AJ.

J Psychiatry Neurosci. 2000 Nov;25(5):481-96. Review.

18.
19.

The trace amines and their acidic metabolites in depression--an overview.

Davis BA, Boulton AA.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jan;18(1):17-45. Review.

PMID:
8115671
20.
Items per page

Supplemental Content

Write to the Help Desk